-
U.S. Boulder Study: Zoning Office Approves New Study Site
-
U.S. Boulder Study: DEA Inspects Site, Delays Study Initiation
-
U.S. Boulder Study: DEA Approves MDMA/PTSD Protocol, Reviews License
-
U.S. Boulder Study: FDA Gives Official Go-Ahead for New Boulder Study
-
U.S. Boulder Study: DEA Conducts Inspection of MDMA Storage Facility
-
U.S. Boulder Study: Therapist Teams Complete Training in South Carolina
-
U.S. Intern Study: Protocol Passes 30-Day FDA Review Period, Cleared for Initiation
-
U.S. Intern Study: IRB Grants Unconditional Approval for Study Protocol
-
U.S. Boulder Study: IRB Grants Conditional Approval, Protocol Submitted to FDA
-
U.S. Boulder Study: Protocol Submitted to FDA
-
U.S. Boulder Study: Study Protocol Under Development